Camazepam[2] is a benzodiazepine psychoactive drug, marketed under the brand names Albego, Limpidon and Paxor.

[14] Studies in dogs have shown that the half-life of the terminal elimination phase ranged from 6.4 to 10.5 h.[15] Camazepam is indicated for the short-term treatment of insomnia and anxiety.

[16] As with other benzodiazepines, its use should be reserved for patients in which the sleep disorder is severe, disabling, or causes marked distress.

[20] Research has demonstrated that Camazepam exhibits competitive binding to benzodiazepine receptors within the brain, albeit with a relatively modest affinity in animal models.

This interaction with benzodiazepine receptors, facilitated by both Camazepam and its active metabolites, is accountable for the medication's anticonvulsant properties.